Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Everest Organics Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

6 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Everest Organics Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Everest Organics Q4 net profit down 9.62% at Rs 2.63 cr

    30 May 2026, 4:50PM The company reported standalone net profit of Rs 2.63 crore for the quarter ended March 31, 2026 as compared to Rs 2.91 crore in the same period last
  • Everest Organics - Announcement under Regulation 30 (LODR)-Change in Directorate

    29 May 2026, 9:14PM Appointment of Mr. Narra Venkata Ramana, as Additional Director in the Board Meeting held today i.e. May 29, 2026.
  • Everest Organics - Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. May 29, 2026.

    29 May 2026, 9:08PM Outcome of the Board Meeting held today .i.e. May 29, 2026.
  • Everest Organics - Audited Financials Results For The Quarter And Year Ended March 31, 2026.

    29 May 2026, 9:05PM Audited Financial Results for quarter and year ended March 31, 2026.
  • Everest Organics - Board Meeting Intimation for Meeting Scheduled To Be Held On 29Th May 2026.

    21 May 2026, 1:30PM Everest Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and
  • Everest Organics has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    13 Apr 2026, 5:10PM As of March 2026, 59.58% is owned by Promoters and 40.42% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 57.84% and Fore
  • Everest Organics - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    10 Apr 2026, 3:07PM Submission of certificate under Reg. 74(5) of SEBI (DP) Regulation for the quarter ended March 31, 2026.

Key fundamentals

Evaluate the intrinsic value of Everest Organics Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 125.4121 117.8214 103.6287 97.2623 85.5772
Liabilities 125.4121 117.8214 103.6287 97.2623 85.5772
Equity 9.7105 9.7105 8 8 8
Gross Profit 19.8107 7.2229 10.9866 0.9298 6.4276
Net Profit 5.5465 -1.2903 0.1392 -0.1822 1.1437
Cash From Operating Activities 4.1819 -5.3769 16.4201 18.4179 13.7374
NPM(%) 2.82 -0.8 0.07 -0.09 0.57
Revenue 196.1577 159.479 197.2412 183.0484 200.0466
Expenses 176.347 152.2561 186.2546 182.1186 193.619
ROE(%) 7.61 -1.77 0.19 -0.25 1.56

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Everest Organics Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 687.50 -2.88 0.00 142.74 -26.19 0.72
Lotus Eye Hospital and Institute Ltd 117.75 -5.50 3930.67 520.12 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 17.42 -0.06 0.00 1079.93 -39.50 0.00
Astec Lifesciences Ltd 770.50 1.94 0.00 490.48 -363.14 0.00

Company Info

Everest Organics Limited, a company with its registered office at Hyderabad, was incorporated on 19th February, 1993. The company has subsequently obtained the certificate of commencement of business on 17th March, 1993. The factory of the company is situated at Aroor Village, Sadasivpet Mandal, Medak district, A.P. The unit is eligible for incentives like State Subsidy, Sales Tax deferment and Power Tariff etc., as the unit is being located in Notified Backward Area. The main objects of the company is to carry on the business of manufacturing, selling of bulk drugs and formulations, which are fully set out in its Memorandum and Articles of Association and are also mentioned below in this prospectus. M/s Everest Organics Limited, envisages to set up a project with a total outlay of Rs.1850 lakhs for Manufacturing Bulk Drugs namely; Para Hydroxy Phenyl Clycine (PHPC) (totally an Import substitute), Omeprazole, Ciprofloxacin, at Aroor Village, Sadasivpet Mandal, Medak district, A.P. As per the schedule given in the project appraisal, the plant will go into Commercial Production by the end of September, 1995. However, the management is confident of implementing the project ahead of the timeframe given in the implementation schedule and starting Commercial Production by July, 1995, i.e.; 2 months ahead of schedule. 2020 - Everest Organics successfully develops Remdesivir API

Everest Organics Limited, a company with its registered office at Hyderabad, was incorporated on 19th February, 1993. The company has subsequently obtained the certificate of commencement of business on 17th March, 1993. The factory of the company is situated at Aroor Village, Sadasivpet Mandal, Medak district, A.P. The unit is eligible for incentives like State Subsidy, Sales Tax deferment and Power Tariff etc., as the unit is being located in Notified Backward Area. The main objects of the company is to carry on the business of manufacturing, selling of bulk drugs and formulations, which are fully set out in its Memorandum and Articles of Association and are also mentioned below in this prospectus. M/s Everest Organics Limited, envisages to set up a project with a total outlay of Rs.1850 lakhs for Manufacturing Bulk Drugs namely; Para Hydroxy Phenyl Clycine (PHPC) (totally an Import substitute), Omeprazole, Ciprofloxacin, at Aroor Village, Sadasivpet Mandal, Medak district, A.P. As per the schedule given in the project appraisal, the plant will go into Commercial Production by the end of September, 1995. However, the management is confident of implementing the project ahead of the timeframe given in the implementation schedule and starting Commercial Production by July, 1995, i.e.; 2 months ahead of schedule. 2020 - Everest Organics successfully develops Remdesivir API

Read More

Parent Organisation

Everest Organics Ltd.

Founded

19/02/1993

Managing Director

Dr.Sri Kakarlapudi Sirisha

NSE Symbol

FAQ

The current price of Everest Organics Ltd is

The 52-week high for Everest Organics Ltd is

The market capitalization of Everest Organics Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Everest Organics Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Everest Organics Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Everest Organics Ltd shares.

The CEO of Everest Organics Ltd is Dr.Sri Kakarlapudi Sirisha, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT